Counterfeit Medicines : Bitter pills  

Oleh:

Jack, Andrew

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: British Medical Journal (keterangan: ada di Proquest) vol. 335 no. 7630 (Dec. 2007), page 1120.

Ketersediaan

Perpustakaan FK Nomor Panggil: B16.K.2007.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

When the UK medicines watchdog unveiled its first ever strategy to tackle counterfeiting last week,1 it was responding to growing concern about the increasingly complex, dangerous, and expanding international traffic in fake drugs. A few weeks earlier, the Medicines and Healthcare Products Regulatory Agency had brought to trial one of the most ambitious prosecutions to date, leading to the imprisonment of four men for handling £1.5m (2m; $3m) in counterfeits.2 Other cases concerning still more elaborate schemes are scheduled in the months ahead. In the past three years, the agency has issued nine withdrawal notices for suspect prescription medicines discovered in the legal distribution chain, compared with just one in the previous decade. Pharmaceutical companies such as Pfizer have been forced into costly withdrawals of batches of their medicines faked by criminals. Growing problem These incidents are almost certainly an underestimate of the extent of the traffic in counterfeit drugs in . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali